Cite
HARVARD Citation
Hellmann, J. et al. (2021). Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease. Pediatric quality & safety. 6 (3), pp. e400-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hellmann, J. et al. (2021). Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease. Pediatric quality & safety. 6 (3), pp. e400-. [Online].